---
title: "KELLEY KENNETH J — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e9d3cf59-78ae-5c8b-add9-77992efe5995
json: https://whiteintel.dev/api/public/dossier/e9d3cf59-78ae-5c8b-add9-77992efe5995
identifier: sec:0001291219
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KELLEY KENNETH J

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001291219`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e9d3cf59-78ae-5c8b-add9-77992efe5995  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e9d3cf59-78ae-5c8b-add9-77992efe5995  

## Ownership & control

### Holdings / subsidiaries

- **HALOZYME THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/69cc61fe-9e71-5735-ab26-f3a37dc83892

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KELLEY KENNETH J**. Human view: https://whiteintel.dev/entity/e9d3cf59-78ae-5c8b-add9-77992efe5995 · Structured JSON: https://whiteintel.dev/api/public/dossier/e9d3cf59-78ae-5c8b-add9-77992efe5995._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._